JPWO2023166045A5 - - Google Patents
Info
- Publication number
- JPWO2023166045A5 JPWO2023166045A5 JP2024550866A JP2024550866A JPWO2023166045A5 JP WO2023166045 A5 JPWO2023166045 A5 JP WO2023166045A5 JP 2024550866 A JP2024550866 A JP 2024550866A JP 2024550866 A JP2024550866 A JP 2024550866A JP WO2023166045 A5 JPWO2023166045 A5 JP WO2023166045A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- oral dosage
- dosage form
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22159408.8 | 2022-03-01 | ||
| EP22159408 | 2022-03-01 | ||
| PCT/EP2023/055160 WO2023166045A1 (en) | 2022-03-01 | 2023-03-01 | Pharmaceutical composition comprising diphenyldiazole derivatives and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508912A JP2025508912A (ja) | 2025-04-10 |
| JPWO2023166045A5 true JPWO2023166045A5 (enExample) | 2026-03-10 |
Family
ID=80623476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024550866A Pending JP2025508912A (ja) | 2022-03-01 | 2023-03-01 | ジフェニルジアゾール誘導体を含む医薬組成物および使用の方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250161273A1 (enExample) |
| EP (1) | EP4486340A1 (enExample) |
| JP (1) | JP2025508912A (enExample) |
| KR (1) | KR20240155237A (enExample) |
| CN (1) | CN118715010A (enExample) |
| AU (1) | AU2023227368A1 (enExample) |
| CA (1) | CA3246018A1 (enExample) |
| CL (1) | CL2024002379A1 (enExample) |
| IL (1) | IL314952A (enExample) |
| MX (1) | MX2024009773A (enExample) |
| PE (1) | PE20250781A1 (enExample) |
| WO (1) | WO2023166045A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025068949A1 (en) | 2023-09-26 | 2025-04-03 | Teva Pharmaceutical Industries Ltd. | Emrusolmin for use in treating multiple system atrophy |
| KR20250090047A (ko) * | 2023-12-12 | 2025-06-19 | 가천대학교 산학협력단 | 긴 탄소사슬을 포함하는 리파펜틴, 암포테리신 b, 세틸피리디늄, 도미펜, 토코페르솔란을 유효성분으로 포함하는 시누클레인병증 치료용 약제학적 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE043090T2 (hu) * | 2008-06-09 | 2019-08-28 | Univ Muenchen Ludwig Maximilians | Gyógyszerek fehérjék aggregálódásának gátlására olyan betegségeknél, amelyek fehérje-aggregálódással és/vagy neurodegeneratív megbetegedésekkel függnek össze |
| AU2016372408B2 (en) * | 2015-12-14 | 2021-05-13 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Water-soluble derivatives of 3,5-diphenyl-diazole compounds |
-
2023
- 2023-03-01 WO PCT/EP2023/055160 patent/WO2023166045A1/en not_active Ceased
- 2023-03-01 MX MX2024009773A patent/MX2024009773A/es unknown
- 2023-03-01 PE PE2024001775A patent/PE20250781A1/es unknown
- 2023-03-01 CA CA3246018A patent/CA3246018A1/en active Pending
- 2023-03-01 JP JP2024550866A patent/JP2025508912A/ja active Pending
- 2023-03-01 EP EP23707119.6A patent/EP4486340A1/en active Pending
- 2023-03-01 CN CN202380024479.XA patent/CN118715010A/zh active Pending
- 2023-03-01 AU AU2023227368A patent/AU2023227368A1/en active Pending
- 2023-03-01 KR KR1020247029979A patent/KR20240155237A/ko active Pending
- 2023-03-01 IL IL314952A patent/IL314952A/en unknown
- 2023-03-01 US US18/840,374 patent/US20250161273A1/en active Pending
-
2024
- 2024-08-08 CL CL2024002379A patent/CL2024002379A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6240646B2 (ja) | カラノライドの医薬組成物及びその調製方法 | |
| CN1235547A (zh) | 用于局部给药工具的含有无环鸟苷的抗疱疹药物组合物 | |
| CZ20012947A3 (cs) | Pouľití esenciálních mastných kyselin pro prevenci kardiovaskulárních příhod | |
| AU2005271413A1 (en) | Novel statin pharmaceutical compositions and related methods of treatment | |
| JP2010506841A (ja) | 抗不整脈薬およびオメガ−３脂肪酸およびそれらの組合せ品による治療法 | |
| US20160199385A1 (en) | Mineral Amino-Acid Complexes of Active Agents | |
| AU2005271407A1 (en) | Novel fenofibrate formulations and related methods of treatment | |
| ES2897024T3 (es) | Composiciones que comprenden agonistas del receptor de PGI2 y procesos para la preparación de las mismas | |
| JP2010509204A5 (enExample) | ||
| JP2005528414A5 (enExample) | ||
| EP4126057B1 (en) | Composition having improved voluntary acceptance | |
| JPWO2023166045A5 (enExample) | ||
| AU2018315094A1 (en) | Methods and compositions for treatment of inflammatory bowel disease | |
| WO2015171516A1 (en) | Compositions and methods relating to ionic salts of peptides | |
| US20140314844A1 (en) | Oral complex formulation comprising omega-3 fatty acid and hmg-coa reductase inhibitor with improved stability | |
| KR20070058632A (ko) | 레르카니디핀 캡슐 | |
| WO2015013395A1 (en) | Methods for reducing triglyceride, total cholesterol and low density lipoprotein blood levels | |
| JP3748912B2 (ja) | オーレオバシジン類の高濃度溶液製剤 | |
| TW201827047A (zh) | 用於預防及/或治療惡病質的ω-3脂肪酸組合物 | |
| RU2398577C2 (ru) | Новые композиции фенофибрата и соответствующие способы лечения | |
| HK1023723A (en) | Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators | |
| JPH05139968A (ja) | メダラシン活性促進剤 | |
| CN101035518A (zh) | 乐卡地平胶囊 |